It has also been reported that WFDC4 may stimulate the invasion of ovarian cancer, partly through its antiprotease activity to reduce the releasing of MMP-9, while its role in inducing MMP-9 does not depend on protease inhibitory activity (Hoskins et al., 2011). Here, SLPI is linked to ovarian carcinoma.